Overview

An Observational Study Investigating the Safety and Effectiveness of Repaglinide in Chinese Patients

Status:
Completed
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
This study is conducted in Asia. The aim of this observational study is, under normal clinical practice conditions, to investigate the clinical safety and effectiveness in Chinese patients with type 2 diabetes who have never received anti-diabetic treatment before.
Details
Lead Sponsor:
Novo Nordisk A/S
Treatments:
Repaglinide